Raminderjit Kaur Selected Research

Hyperglycemia

1/2018

Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raminderjit Kaur Research Topics

Disease

2	Inflammation (Inflammations) 01/2022 - 01/2018
2	Neoplasms (Cancer) 01/2021 - 05/2019
2	Type 2 Diabetes Mellitus (MODY) 05/2020 - 02/2019
1	Latent Tuberculosis 01/2022
1	Hyperplasia 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Opportunistic Infections (Opportunistic Infection) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 05/2019
1	Insulin Resistance 01/2018
1	Hyperglycemia 01/2018

Drug/Important Bio-Agent (IBA)

2	silk elastin-like protein (SELP)IBA 05/2020 - 02/2019
2	SelectinsIBA 05/2020 - 02/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	CytokinesIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	enterocinIBA 01/2021
1	SilverIBA 05/2019
1	P-SelectinIBA 02/2019
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018

Therapy/Procedure

1	Therapeutics 01/2022